Stock CDIO CARDIO DIAGNOSTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Cardio Diagnostics Holdings, Inc.

Equities

CDIO

US14159C1036

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 07:41:21 16/05/2024 pm IST 		5-day change 1st Jan Change
0.851 USD +0.50% Intraday chart for Cardio Diagnostics Holdings, Inc. +12.70% -67.07%
29/04 Cardio Diagnostics Holdings, Inc. Announces Publication of Study Showing That Its PrecisionCHD Test Could Save Health Insurers over $113 Million Annually CI
19/04 Sector Update: Health Care Stocks Advance Late Afternoon MT

Business Summary

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Number of employees: 8

Sales per Business

USD in Million2022Weight2023Weight Delta
Artificial Intelligence-driven DNA Biomarker Testing Technology
100.0 %
0 100.0 % 0 100.0 % +1,696.32%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 0 100.0 % +1,696.32%

Managers

Managers TitleAgeSince
Meeshanthini Dogan CEO
 Chief Executive Officer 35 25/22/25
Elisa Luqman DFI
 Director of Finance/CFO 59 25/22/25
Timur Dogan CTO
 Chief Tech/Sci/R&D Officer 36 25/22/25
Robert Philibert CTO
 Chief Tech/Sci/R&D Officer 63 25/22/25
Khullani Abdullahi IRO
 Public Communications Contact 41 25/22/25
Gene Mannheimer IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Warren Hosseinion CHM
 Chairman 52 25/22/25
Oded Levy BRD
 Director/Board Member 63 25/22/25
Paul Burton BRD
 Director/Board Member - 21/12
Stanley Lau BRD
 Director/Board Member 68 25/22/25
Meeshanthini Dogan CEO
 Chief Executive Officer 35 25/22/25
Robert Philibert CTO
 Chief Tech/Sci/R&D Officer 63 25/22/25
James Intrater BRD
 Director/Board Member 60 25/22/25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 21,591,119 17,758,070 ( 82.25 %) 0 82.25 %

Shareholders

NameEquities%Valuation
Robert Philibert
7.641 %
1,649,792 7.641 % 1 M $
Meeshanthini Dogan
7.348 %
1,586,464 7.348 % 1 M $
BlackRock Fund Advisors
4.942 %
1,067,062 4.942 % 770 419 $
BlackRock Institutional Trust Co. NA
4.942 %
1,067,062 4.942 % 770 419 $
Vanguard Group, Inc. (Subfiler)
1.075 %
232,139 1.075 % 167 604 $
Geode Capital Management LLC
0.7053 %
152,292 0.7053 % 109 955 $
Timur Dogan
0.5944 %
128,345 0.5944 % 92 665 $
Warren Hosseinion
0.5375 %
116,053 0.5375 % 83 790 $
Stanley Lau
0.4239 %
91,522 0.4239 % 66 079 $
James Intrater
0.2908 %
62,793 0.2908 % 45 337 $
NameEquities%Valuation
Walleye Capital LLC
-
234,907 - 13 860 $
EHP Funds, Inc.
-
228,952 - 13 508 $
EdgeHill Partners
-
228,952 - 13 508 $
Saba Capital Management LP
-
199,839 - 11 791 $
Walleye Trading LLC
-
132,265 - 7 804 $
Clear Street LLC
-
83,142 - 4 905 $
Context Capital Management LLC
-
81,500 - 4 809 $
D.E. Shaw & Co., Inc.
-
74,822 - 4 414 $
Boothbay Fund Management LLC
-
60,540 - 3 572 $
HRT Financial LLC
-
36,936 - 2 179 $

Company contact information

Cardio Diagnostics Holdings, Inc.

311 West Superior Street Suite 444

60654, Chicago

+

http://www.cardiodiagnosticsinc.com
address Cardio Diagnostics Holdings, Inc.(CDIO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Ratings for Cardio Diagnostics Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8468 USD
Average target price
4.675 USD
Spread / Average Target
+452.08%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
CARDIO DIAGNOSTICS HOLDINGS, INC. Stock Cardio Diagnostics Holdings, Inc.
-67.07% 1.83Cr
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+6.68% 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.97% 11TCr
ARGENX SE Stock argenx SE
+0.90% 2.23TCr
BIONTECH SE Stock BioNTech SE
-12.53% 2.22TCr
GENMAB A/S Stock Genmab A/S
-5.61% 1.94TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-37.85% 1.79TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-6.52% 1.72TCr
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.45% 1.43TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+34.67% 1.25TCr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. CDIO Stock
  4. Company Cardio Diagnostics Holdings, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW